Beta Bionics Affirms FY2026 Sales Guidance of $131.000M-$136.000M vs $133.305M Est
Benzinga Newsdesk 3 months ago
NewsGuidance
Beta Bionics (NASDAQ:BBNX) affirms FY2026 sales outlook from $131.000 million-$136.000 million to $131.000 million-$136.000 million vs $133.305 million estimate.
Beta Bionics (NASDAQ:BBNX) affirms FY2026 sales outlook from $131.000 million-$136.000 million to $131.000 million-$136.000 million vs $133.305 million estimate.